Ignite Creation Date:
2025-12-24 @ 9:36 PM
Ignite Modification Date:
2026-01-26 @ 6:29 PM
Study NCT ID:
NCT00613132
Status:
COMPLETED
Last Update Posted:
2013-02-20
First Post:
2008-01-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG
Sponsor:
Annick Desjardins
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Glioblastoma | View |
| None | Gliosarcoma | View |
| None | GBM | View |
| None | Brain tumor | View |
| None | RAD0001 | View |
| None | Hydroxyurea | View |
| None | Gleevec | View |
| None | Imatinib | View |
| None | Droxia | View |
| None | Everolimus | View |
| None | Hydrea | View |
| None | Hydroxycarbamide | View |
| None | Recurrent GBM | View |
| None | Imatinib mesylate | View |
| None | Glioblastoma multiforme | View |